Effects of Ultramicronized
PEA
astrocyte
opioid
oxycodone
pain therapy
tolerance
tramadol
Journal
Pharmaceutics
ISSN: 1999-4923
Titre abrégé: Pharmaceutics
Pays: Switzerland
ID NLM: 101534003
Informations de publication
Date de publication:
11 Feb 2022
11 Feb 2022
Historique:
received:
03
12
2021
revised:
04
02
2022
accepted:
07
02
2022
entrez:
26
2
2022
pubmed:
27
2
2022
medline:
27
2
2022
Statut:
epublish
Résumé
Chronic pain management requires increasing doses of opioids, the milestone of painkillers, which may result in the onset of tolerance with exacerbated side effects. Maintaining stable analgesia with low doses of opioids is thus imperative.
Identifiants
pubmed: 35214131
pii: pharmaceutics14020403
doi: 10.3390/pharmaceutics14020403
pmc: PMC8875545
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : University of Florence
ID : not available
Organisme : Ministry of Education, Universities and Research
ID : not available
Références
Lancet. 1999 Jun 5;353(9168):1959-64
pubmed: 10371588
CNS Neurol Disord Drug Targets. 2013 Feb 1;12(1):17-25
pubmed: 23394522
Arterioscler Thromb Vasc Biol. 2018 Nov;38(11):2562-2575
pubmed: 30354245
Br J Pharmacol. 1988 Mar;93(3):553-60
pubmed: 2836010
CNS Neurol Disord Drug Targets. 2013 Feb 1;12(1):45-54
pubmed: 23394524
PLoS One. 2015 Jun 03;10(6):e0128080
pubmed: 26039098
Biochem Biophys Res Commun. 1979 Sep 27;90(2):628-33
pubmed: 508325
Neurotherapeutics. 2021 Oct;18(4):2722-2736
pubmed: 34553321
Brain Behav Immun. 2009 Jan;23(1):75-84
pubmed: 18684397
J Pharmacol Exp Ther. 2012 Jul;342(1):188-95
pubmed: 22514334
Biochem Pharmacol. 2011 Aug 15;82(4):380-8
pubmed: 21601562
Trends Neurosci. 1996 Nov;19(11):514-20
pubmed: 8931279
Pain Med. 2008 May-Jun;9(4):444-59
pubmed: 18489635
J Allergy. 1959 Sep-Oct;30:415-9
pubmed: 13826312
CNS Neurol Disord Drug Targets. 2013 Feb 1;12(1):55-61
pubmed: 23394520
Proc Natl Acad Sci U S A. 2009 Dec 8;106(49):20966-71
pubmed: 19926854
Pharmaceuticals (Basel). 2021 Oct 27;14(11):
pubmed: 34832873
Front Pharmacol. 2018 Mar 20;9:249
pubmed: 29615912
Pharmacol Toxicol. 1990 Oct;67(4):322-8
pubmed: 2077525
Epilepsia. 2001 Mar;42(3):321-7
pubmed: 11442148
Animals (Basel). 2021 Mar 29;11(4):
pubmed: 33805489
Int J Mol Sci. 2020 Dec 15;21(24):
pubmed: 33333772
Biomed Res Int. 2015;2015:894732
pubmed: 25874232
Antioxidants (Basel). 2020 Mar 05;9(3):
pubmed: 32150935
J Pain. 2013 Dec;14(12):1585-600
pubmed: 24135431
J Histochem Cytochem. 1991 May;39(5):561-8
pubmed: 1707903
Neuropsychopharmacology. 2012 Jun;37(7):1784-92
pubmed: 22414817
J Neurosci. 2002 Nov 15;22(22):9980-9
pubmed: 12427855
J Neurosci. 2013 Oct 2;33(40):15952-63
pubmed: 24089500
Pain Physician. 2008 Mar;11(2 Suppl):S105-20
pubmed: 18443635
Front Pharmacol. 2017 Dec 12;8:857
pubmed: 29311913
Neuron. 2019 Feb 6;101(3):412-420.e3
pubmed: 30686732
Acta Anaesthesiol Scand. 1998 May;42(5):576-80
pubmed: 9605375
Drug Discov Today. 2014 Oct;19(10):1632-9
pubmed: 24952959
Eur J Clin Pharmacol. 2018 Nov;74(11):1461-1469
pubmed: 30051214
J Pain Palliat Care Pharmacother. 2011;25(1):29-31
pubmed: 21426215
Br J Pharmacol. 2008 Nov;155(6):837-46
pubmed: 18695637
Neuropharmacology. 2017 Jul 15;121:158-166
pubmed: 28450061
Exp Neurol. 2014 Nov;261:22-33
pubmed: 24967684
Clin J Pain. 2002 Jul-Aug;18(4 Suppl):S3-13
pubmed: 12479250
Mol Pharmacol. 2005 Jan;67(1):15-9
pubmed: 15465922
CNS Neurol Disord Drug Targets. 2016;15(9):1072-1078
pubmed: 27573801
Vet Sci. 2020 Jun 16;7(2):
pubmed: 32560159
Pharmacol Rep. 2008 May-Jun;60(3):297-307
pubmed: 18622054
Eur J Anaesthesiol. 1994 May;11(3):221-30
pubmed: 7914167
Pain Med. 2008 Apr;9(3):271-81
pubmed: 18366507
Front Pharmacol. 2018 Jun 01;9:473
pubmed: 29910726
BMC Med. 2010 Jan 20;8:8
pubmed: 20089155
Anesth Analg. 2007 Jul;105(1):8-9
pubmed: 17578943
Neurosci Lett. 2020 Jan 18;716:134638
pubmed: 31756370
Cochrane Database Syst Rev. 2017 Oct 30;10:CD012509
pubmed: 29084357
Acta Anaesthesiol Scand. 1986 Nov;30(8):620-4
pubmed: 3544648
Clin J Pain. 1990 Sep;6(3):212-20
pubmed: 2135015
Mol Neurobiol. 2015 Oct;52(2):1034-42
pubmed: 26055231
Eur J Pharmacol. 1996 Apr 11;300(3):227-36
pubmed: 8739213
Front Immunol. 2020 Mar 04;11:300
pubmed: 32194554
Mediators Inflamm. 2013;2013:328797
pubmed: 23533304
Anesth Analg. 2005 Jun;100(6):1740-1745
pubmed: 15920207
Front Pharmacol. 2019 Jul 24;10:821
pubmed: 31396087
CNS Neurol Disord Drug Targets. 2013 Feb 1;12(1):23-33
pubmed: 23394528
Agents Actions. 1993;39 Spec No:C145-7
pubmed: 7505999
Mol Neurobiol. 2013 Oct;48(2):340-52
pubmed: 23813098
FASEB J. 2012 Aug;26(8):3103-17
pubmed: 22516295
Neuroscientist. 2004 Feb;10(1):40-52
pubmed: 14987447
N Engl J Med. 2017 Jul 27;377(4):391-394
pubmed: 28564549
PLoS One. 2012;7(8):e41880
pubmed: 22912680
Molecules. 2021 Jul 19;26(14):
pubmed: 34299631
Immunology. 2014 Mar;141(3):314-27
pubmed: 24032675
Pain. 1998 Sep;77(3):227-229
pubmed: 9808347
Br J Pharmacol. 2015 Jul;172(13):3189-93
pubmed: 25964986